Durlobactam sodium; durlobactam sodium; sulbactam sodium - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for durlobactam sodium; durlobactam sodium; sulbactam sodium and what is the scope of freedom to operate?

Durlobactam sodium; durlobactam sodium; sulbactam sodium is the generic ingredient in one branded drug marketed by Entasis Therap and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Durlobactam sodium; durlobactam sodium; sulbactam sodium has seventy-eight patent family members in forty-two countries.

One supplier is listed for this compound.

Summary for durlobactam sodium; durlobactam sodium; sulbactam sodium

International Patents:	78
US Patents:	4
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
DailyMed Link:	durlobactam sodium; durlobactam sodium; sulbactam sodium at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for durlobactam sodium; durlobactam sodium; sulbactam sodium

Generic Entry Date for durlobactam sodium; durlobactam sodium; sulbactam sodium^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: GENERATING ANTIBIOTIC INCENTIVES NOW Dosage: POWDER;INTRAVENOUS

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Anatomical Therapeutic Chemical (ATC) Classes for durlobactam sodium; durlobactam sodium; sulbactam sodium

J01CG	Beta-lactamase inhibitors
J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for durlobactam sodium; durlobactam sodium; sulbactam sodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for durlobactam sodium; durlobactam sodium; sulbactam sodium

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Singapore	11201405965R	HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS	⤷ Sign Up
Taiwan	I597281		⤷ Sign Up
Philippines	12014502224	HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS	⤷ Sign Up
Eurasian Patent Organization	033829	КОМБИНИРОВАННАЯ ТЕРАПИЯ ДЛЯ ЛЕЧЕНИЯ УСТОЙЧИВЫХ БАКТЕРИАЛЬНЫХ ИНФЕКЦИЙ (COMBINATION THERAPY FOR TREATMENT OF RESISTANT BACTERIAL INFECTIONS)	⤷ Sign Up
Canada	2866467	COMPOSES HETEROBICYCLIQUES COMME INHIBITEURS DE LA BETA-LACTAMASE (HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2016081452		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Summary for durlobactam sodium; durlobactam sodium; sulbactam sodium

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for durlobactam sodium; durlobactam sodium; sulbactam sodium

Anatomical Therapeutic Chemical (ATC) Classes for durlobactam sodium; durlobactam sodium; sulbactam sodium

Make Better Decisions: Try a trial or see plans & pricing

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for durlobactam sodium; durlobactam sodium; sulbactam sodium